Chemetall

Although Albemarle Corporation (NYSE: ALB) shares meaningfully appreciated in 2016, Baird’s Ben Kallo believes there still is substantial upside potential to the stock, given that the company is in the early stages of a multi-year cycle of lithium demand. Kallo upgraded the rating on the...

Albemarle Corporation (NYSE: ALB)'s Chemetall sale "accelerates path to de-levering." Citi Bank's P.J. Juvekar reiterates his Buy rating on Albemarle, the top pick on Citi's focus list, with a price target of $89. The company's surface treatment (Chemetall) business was bought at a fair price,...